Navigation Links
Researchers propose a novel prognostic model for disease-specific survival in BCa patients
Date:3/18/2013

Milan, 18 March 2013 A new study from Japan investigated various prognostic indicators, including clinico-pathological and pre-operative hematological factors to develop a novel prognostic factors-based risk stratification model for disease-specific survival (DSS) in bladder cancer (BCa) patients treated with radical cystectomy (RC).

This large series demonstrated that two types of pre-operative haematological disorders assessed by haemoglobin (Hb) and C-reacted protein (CRP) are independent prognostic indicators for patients with BCa treated by RC.

"Despite the wealth of evidence on the oncological significance of various clinico-pathological and molecular parameters for survival in invasive BCa patients treated with radical cystectomy, alterations of pre-operative haematological parameters have not been sufficiently addressed," write the authors of the study.

"The findings suggest that pre-operative Hb and CRP levels, which can be easily obtained during routine practice, provide additional independent prognostic information for DSS. Moreover, our risk stratification model, which combines both hematological and pathological parameters, may provide physicians with useful prognostic information for identifying patients who may be candidates for multimodal treatment, including innovative adjuvant treatments."

In the course of the study, the researchers performed a retrospective analysis of 249 consecutive BCa patients treated with RC without neoadjuvant therapy at several institutions.

Prognostic value of the pre-operative hematological laboratory parameters along with patient's clinico-pathological parameters were evaluated by univariate and multivariate Cox proportional hazard model analyses. Based on these data, the scientists developed a new scoring model to predict DSS after RC using the regression coefficients of the multivariate model.

One-, 3-, and 5-year DSS rates were 89.1%, 69.3%, and 62.7%, respectively. In multivariate analysis, pre-operative values of low hemoglobin (Hb) (< 10g /dL) and high C-reacted protein (CRP) (> 0.5 mg / dL), pathological T stage (≥ pT3a), lympho-vascular invasion (LVI) and positive surgical margin (PSM) status were independent factors for predicting poor prognosis. The score was calculated as 2 (if PSM) + 2 (Hb < 10g /dL) + 1 (if ≥ pT3a) + 1 (if LVI) + 1 (CRP > 0.5 mg / dL) and 0 (if otherwise).

The 4-year DSS in patients with a score in the ranges 0-1 (low-risk), 2-3 (intermediate-risk) and 4-7 (high-risk) was 83.4%, 48.8% and 5.9%, respectively All differences in DSS between subgroups were P < 0.0001.


'/>"/>

Contact: i.moerkerken@uroweb.org
i.moerkerken@uroweb.org
31-026-389-0680
European Association of Urology
Source:Eurekalert

Related medicine news :

1. More parents say they wont vaccinate daughters against HPV, researchers find
2. Kessler Foundation researchers share findings in rehabilitation research at AAN meeting in San Diego
3. Mayo Clinic and Illinois researchers develop new sensor for methylated DNA
4. Researchers advance fight against biggest hidden virus
5. Brain researcher James Poulet receives the 2013 Paul Ehrlich Prize for Young Researchers
6. Bradley Hospital researchers find age-related changes in how autism affects the brain
7. LA BioMed physician-researchers honored as top doctors
8. IU researchers receive $3.2 million to develop, improve therapies for pancreatic cancer
9. Cancer researchers discover new type of retinoblastoma in babies
10. Researchers Turn from Drugs to Mini Organs for Diabetes Cure, According to Yasmin Malhotra
11. Researchers develop new tool to eliminate 30-day hospital readmissions in heart failure patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Story Highlights: , ... health care industry is causing providers to review operating ... offers a suite of solutions for health care providers ... optimization: labor resource analysis, revenue cycle optimization and physician ... and better economics ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
Breaking Medicine Technology: